BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Treatment
20 results:

  • 1. Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer.
    Qiu J; Zhao Z; Suo H; Paraghamian SE; Hawkins GM; Sun W; Zhang X; Hao T; Deng B; Shen X; Zhou C; Bae-Jump V
    Cancer Biol Ther; 2024 Dec; 25(1):2325130. PubMed ID: 38465855
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer
    O'Donnell J; Zhao Z; Buckingham L; Hao T; Suo H; Zhang X; Fan Y; John C; Deng B; Shen X; Sun W; Secord AA; Zhou C; Bae-Jump VL
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503790
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
    Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
    Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial cancer.
    Dobroch J; Bojczuk K; Kołakowski A; Baczewska M; Knapp P
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408440
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1-Positive Recurrent or Metastatic Cervical cancer: A Multicenter, Single-Arm, Prospective Phase II Trial.
    Xu Q; Wang J; Sun Y; Lin Y; Liu J; Zhuo Y; Huang Z; Huang S; Chen Y; Chen L; Ke M; Li L; Li Z; Pan J; Song Y; Liu R; Chen C
    J Clin Oncol; 2022 Jun; 40(16):1795-1805. PubMed ID: 35192397
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Obesity and altered angiogenic-related gene expression in endometrial cancer.
    Cobb LP; Siamakpour-Reihani S; Zhang D; Qin X; Owzar K; Zhou C; Conrads TP; Maxwell GL; Darcy KM; Bateman NW; Litzi T; Bae-Jump V; Secord AA
    Gynecol Oncol; 2021 Nov; 163(2):320-326. PubMed ID: 34538531
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.
    Huang X; He M; Peng H; Tong C; Liu Z; Zhang X; Shao Y; Zhu D; Zhang J; Yin JC; Yang F; Lan C
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011535
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.
    Gadducci A; Biglia N; Tana R; Cosio S; Gallo M
    Crit Rev Oncol Hematol; 2016 Sep; 105():73-83. PubMed ID: 27378194
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. lkb1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.
    Peña CG; Nakada Y; Saatcioglu HD; Aloisio GM; Cuevas I; Zhang S; Miller DS; Lea JS; Wong KK; DeBerardinis RJ; Amelio AL; Brekken RA; Castrillon DH
    J Clin Invest; 2015 Nov; 125(11):4063-76. PubMed ID: 26413869
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical cancer Patients.
    de la Rochefordiere A; Kamal M; Floquet A; Thomas L; Petrow P; Petit T; Pop M; Fabbro M; Kerr C; Joly F; Sevin E; Maillard S; Curé H; Weber B; Brunaud C; Minsat M; Gonzague L; Berton-Rigaud D; Aumont M; Gladieff L; Peignaux K; Bernard V; Leroy Q; Bieche I; Margogne A; Nadan A; Fourchotte V; Diallo A; Asselain B; Plancher C; Armanet S; Beuzeboc P; Scholl SM
    Clin Cancer Res; 2015 Jun; 21(11):2530-7. PubMed ID: 25724520
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Metformin: a modulator of bevacizumab activity in cancer? A case report.
    Indraccolo S; Randon G; Zulato E; Nardin M; Aliberti C; Pomerri F; Casarin A; Nicoletto MO
    Cancer Biol Ther; 2015; 16(2):210-4. PubMed ID: 25607951
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Successful pregnancy in a Peutz-Jeghers syndrome patient with lobular endocervical glandular hyperplasia.
    Takei Y; Fujiwara H; Nagashima T; Takahashi Y; Takahashi S; Suzuki M
    J Obstet Gynaecol Res; 2015 Mar; 41(3):468-73. PubMed ID: 25257303
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and lkb1 Is highly responsive to mTOR inhibition.
    Cheng H; Liu P; Zhang F; Xu E; Symonds L; Ohlson CE; Bronson RT; Maira SM; Di Tomaso E; Li J; Myers AP; Cantley LC; Mills GB; Zhao JJ
    Cancer Res; 2014 Jan; 74(1):15-23. PubMed ID: 24322983
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.
    Trédan O; Treilleux I; Wang Q; Gane N; Pissaloux D; Bonnin N; Petit T; Cretin J; Bonichon-Lamichhane N; Priou F; Lavau-Denes S; Mari V; Freyer G; Lebrun D; Alexandre J; Ray-Coquard I
    Target Oncol; 2013 Dec; 8(4):243-51. PubMed ID: 23238879
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Stromal liver kinase B1 [stk11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1.
    Tanwar PS; Kaneko-Tarui T; Zhang L; Tanaka Y; Crum CP; Teixeira JM
    PLoS Genet; 2012; 8(8):e1002906. PubMed ID: 22916036
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Metformin impairs the growth of liver kinase B1-intact cervical cancer cells.
    Xiao X; He Q; Lu C; Werle KD; Zhao RX; Chen J; Davis BC; Cui R; Liang J; Xu ZX
    Gynecol Oncol; 2012 Oct; 127(1):249-55. PubMed ID: 22735790
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Peutz-Jeghers syndrome: diagnostic and therapeutic approach.
    Kopacova M; Tacheci I; Rejchrt S; Bures J
    World J Gastroenterol; 2009 Nov; 15(43):5397-408. PubMed ID: 19916169
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
    Yu SY; Chan DW; Liu VW; Ngan HY
    Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of lkb1.
    Nafz J; De-Castro Arce J; Fleig V; Patzelt A; Mazurek S; Rösl F
    Biochem J; 2007 May; 403(3):501-10. PubMed ID: 17212587
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome.
    Srivatsa PJ; Keeney GL; Podratz KC
    Gynecol Oncol; 1994 May; 53(2):256-64. PubMed ID: 8188091
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.